0001209191-18-054606.txt : 20181009 0001209191-18-054606.hdr.sgml : 20181009 20181009191838 ACCESSION NUMBER: 0001209191-18-054606 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181004 FILED AS OF DATE: 20181009 DATE AS OF CHANGE: 20181009 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SKIBSTED RUSSELL CENTRAL INDEX KEY: 0001308105 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12830 FILM NUMBER: 181114681 MAIL ADDRESS: STREET 1: 15 TRANQUILITY PLACE CITY: LADERA RANCH STATE: CA ZIP: 92694 FORMER NAME: FORMER CONFORMED NAME: Skibsted Russell DATE OF NAME CHANGE: 20041108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOTIME INC CENTRAL INDEX KEY: 0000876343 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943127919 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1010 ATLANTIC AVENUE STREET 2: SUITE 102 CITY: ALAMEDA STATE: CA ZIP: 94501 BUSINESS PHONE: 5105213390 MAIL ADDRESS: STREET 1: 1010 ATLANTIC AVENUE STREET 2: SUITE 102 CITY: ALAMEDA STATE: CA ZIP: 94501 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-10-04 0 0000876343 BIOTIME INC BTX 0001308105 SKIBSTED RUSSELL 1010 ATLANTIC AVENUE, SUITE 102 ALAMEDA CA 94501 0 1 0 0 Chief Financial Officer Common Shares, no par value 2018-10-04 4 M 0 11250 0.00 A 13250 D Common Shares, no par value 2018-10-04 4 F 0 3891 2.22 D 9359 D Restricted Stock Units 0.00 2018-10-04 4 M 0 11250 0.00 D Common Shares 11250 33750 D Shares earned by the Reporting Person as a result of the vesting of Restrictive Stock Units ("RSUs") granted to the Reporting Person on May 24, 2018. Does not include RSUs payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options. Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 11,250 RSUs, the grant of which was previously reported on a Form 8-K. 25% of the RSUs granted on May 24, 2018 vested on October 4, 2018, then the remaining 75% of the RSUs shall vest based on the sole determination by the Board of Directors that BioTime has achieved certain milestones, subject to the continuing employment of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. /s/Russell Skibsted 2018-10-08